As a proof of concept, in vivo delivery in mice of a specific autophagy inducer peptide, Tat-Beclin1, has demonstrated positive results in the treatment of neurodegenerative disease and viral infections [150]. This evidence concerns the gene BECN1 and viral infectious disease.